This retention rate is consistent with those described in large series. Those studies also show that patients with Crohn's disease and tumors are at the highest risk of EC retention.
Este porcentaje de retención de la CE está acorde con lo descrito en grandes series, que demuestran que los pacientes con enfermedad de Crohn y tumores son los que tienen mayor riesgo de retención de la CE.